In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant <i>Enterococcus faecium</i>

Therapeutic options for infections caused by vancomycin-resistant enterococci are currently suboptimal. Combination regimens where fosfomycin is used alongside existing treatments are emerging given the proven synergistic potential and PK/PD properties. In the studies presented here, we tested five...

詳細記述

書誌詳細
出版年:Antibiotics
主要な著者: Cristina Lagatolla, Jai W. Mehat, Roberto Marcello La Ragione, Roberto Luzzati, Stefano Di Bella
フォーマット: 論文
言語:英語
出版事項: MDPI AG 2022-09-01
主題:
オンライン・アクセス:https://www.mdpi.com/2079-6382/11/10/1334

類似資料